Tarkett - Information On The Total Number Of Voting Rights And Shares In Tarkett's Share Capital As Of November, 30Th, 2025

2025-12-05 03:47:00

(MENAFN- GlobeNewsWire - Nasdaq) PARIS, FRANCE, 5^th of December 2025 - Information on the total number of voting rights and shares in Tarkett's share capital as of November 30^th, 2025

(Article L233-8-II of the French Commercial Code and
Article 223-16 of the General Regulation of the Autorité des marchés financiers)

Date	Total number of shares in the share capital	Total number of voting rights
As of November 30^th, 2025	65,550,281	Number of theoretical voting rights: 123 938 579
Number of exercisable voting rights: 123 920 020*

* After deduction of the treasury shares without voting rights.

***

Investor Relations Contact
...

Media Contact
Tarkett – ...
Ogilvy – ... – +33 6 79 39 75 04
Ogilvy – ... – + 33 6 01 16 08 94

About Tarkett

With a history of more than 140 years, Tarkett is a worldwide leader in innovative and sustainable flooring and sports surface solutions, generating turnover of € 3.3 billion in 2024. The Group has close to 12,000 employees, 24 R&D centers, 8 recycling centers and 35 production sites. Tarkett creates and manufactures solutions for hospitals, schools, housing, hotels, offices, stores and sports fields, serving customers in over 100 countries. To build“The Way to Better Floors,” the Group is committed to circular economy and sustainability, in line with its Tarkett Human-Conscious Design® approach. Tarkett is listed on the Euronext regulated market (compartment B, ISIN: FR0004188670, ticker: TKTT)).

Attachment

PR_Tarkett - Number of voting right November 2025

MENAFN05122025004107003653ID1110441123

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.